thromboembolic events

Related by string. Thromboembolic events * Thromboembolic . thrombo embolic : thromboembolic . thromboembolic disease . thromboembolic complications . thromboembolic disorders / eventing . EVENTS . EVENT . Events : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement * venous thromboembolic events . arterial thromboembolic events *

Related by context. All words. (Click for frequent words.) 79 thrombotic events 79 thromboembolism 77 thromboembolic 74 venous thromboembolic events 74 thromboembolic complications 74 β blockers 73 hematologic toxicity 73 Torsades de Pointes 73 hemorrhagic complications 73 rFVIIa 73 recurrent VTE 73 cerebrovascular events 73 ximelagatran 73 reinfarction 72 TEAEs 72 nephrotoxicity 72 hyperkalemia 72 mycophenolate mofetil 72 intracerebral hemorrhage 72 hypercalcemia 72 Erythropoietic therapies may 72 hepatotoxicity 72 severe hypersensitivity reactions 71 venous thrombosis 71 upper gastrointestinal bleeding 71 intravenous bisphosphonates 71 left ventricular dysfunction 71 discontinuations due 71 thrombotic complications 71 QTc prolongation 71 venous thromboembolism 71 definite stent thrombosis 71 postoperative AF 71 torsades de pointes 71 recurrent DVT 71 recurrent ischemia 71 gastrointestinal toxicity 71 severe exacerbations 70 QTc 70 myocardial infarction MI 70 myopathy rhabdomyolysis 70 Toxicities 70 arterial thromboembolic events 70 myocardial ischemia 70 thromboprophylaxis 70 lumiracoxib 70 renal dysfunction 70 hypomagnesemia 70 carotid stenosis 70 angina pectoris 70 renal insufficiency 70 rebleeding 70 salmeterol HFA MDI 70 tamsulosin 70 cardiac toxicity 70 octreotide LAR 70 nonfatal MI 70 colorectal adenoma 70 perioperative complications 70 symptomatic VTE 70 eptifibatide 69 myocardial infarction stroke 69 unstable angina pectoris 69 GnRH agonists 69 Stent thrombosis 69 posaconazole 69 EXJADE 69 fluvastatin 69 periprocedural 69 perioperative mortality 69 severe neutropenia 69 tirofiban 69 renal toxicity 69 gastrointestinal perforation 69 non valvular atrial 69 proliferative diabetic retinopathy 69 MACCE 69 endometrial hyperplasia 69 cerebral vasospasm 69 QT prolongation 69 ATACAND 69 corticosteroid therapy 69 ischemic complications 69 antiarrhythmic drug 69 dronedarone 69 endophthalmitis 69 MULTAQ 69 beta blocker therapy 69 postoperative complication 69 TNF antagonist 69 locoregional recurrence 69 ARCOXIA 69 fondaparinux 69 invasive candidiasis 69 extrapyramidal symptoms 69 nonvertebral fracture 69 HMG CoA reductase inhibitors 68 Thrombocytopenia 68 systemic embolism 68 abciximab 68 ocular adverse 68 atherothrombotic events 68 CrCl 68 myocardial infarctions 68 deep venous thromboses 68 vertebral fracture 68 ipsilateral stroke 68 heparin induced thrombocytopenia 68 torsade de pointes 68 leiomyomas 68 revascularization procedures 68 cilostazol 68 GP IIb IIIa inhibitors 68 stable angina 68 antithrombotic therapy 68 pheochromocytoma 68 prolonged QT interval 68 PRADAXA #mg 68 paroxysmal AF 68 tibolone 68 variceal bleeding 68 ischemic cardiomyopathy 68 eplerenone 68 hypoglycemic events 68 virologic failure 68 teriflunomide 68 nonmelanoma skin cancers 68 transaminase elevations 68 pericardial effusion 68 acute coronary syndromes ACS 68 recurrent venous thromboembolism 68 nadolol 68 androgen deprivation 68 TMP SMX 68 hematologic adverse 68 revascularizations 68 thromboses 68 thromboembolic disease 68 aspirin clopidogrel 68 TORISEL 68 Febrile neutropenia 68 nonvertebral fractures 67 ticlopidine 67 FASLODEX 67 macrovascular 67 ß blockers 67 vasospasm 67 IIIa inhibitor 67 microvascular complications 67 Adverse events 67 EBRT 67 atypical fractures 67 contrast induced nephropathy 67 ARIXTRA 67 coronary stenosis 67 intracranial hemorrhage ICH 67 carotid artery stenosis 67 NATRECOR R 67 intraoperative complications 67 angiographic restenosis 67 idraparinux 67 prostate TURP 67 patients undergoing CABG 67 liver resection 67 hypersensitivity reaction 67 treatment emergent adverse 67 ventricular tachyarrhythmia 67 Hypotension 67 gout flares 67 proximal DVT 67 clopidogrel Plavix 67 COPD exacerbations 67 VAPRISOL 67 leukopenia 67 neointimal hyperplasia 67 ertapenem 67 PREZISTA r 67 ALT flares 67 elevated ALT 67 APTIVUS r 67 ICD shocks 67 FOLFOX4 67 flutamide 67 revascularisation 67 QTc interval 67 prednisone prednisolone 67 anticoagulation therapy 67 platelet inhibitor 67 febrile neutropenia 67 cobiprostone 67 thrombolytic agents 67 myocardial infarction 67 PRADAXA 67 severe renal impairment 67 vasomotor symptoms 67 simvastatin ezetimibe 67 angioedema 67 carotid endarterectomy CEA 67 advanced adenomas 67 HES CEL 67 NATRECOR ® 67 postoperative atrial fibrillation 67 coadministration 67 intravesical therapy 67 FOLFIRI 67 Postoperative complications 67 symptomatic intracranial 67 anemia hemoglobin 67 adrenalectomy 67 lenalidomide dexamethasone 67 hypoglycaemic episodes 67 endometrial carcinoma 67 bezafibrate 67 CYPHER Stent 67 QT interval prolongation 67 postoperative morbidity 67 infarctions 66 transurethral resection 66 gastrointestinal toxicities 66 chemoradiotherapy 66 fibrinolytic 66 antiplatelet therapy 66 antiarrhythmic drugs 66 paclitaxel eluting stents 66 VIIBRYD 66 ventricular arrhythmia 66 tumor lysis syndrome 66 CMV disease 66 unstable angina UA 66 XIENCE V PROMUS Stent 66 fatal myocardial infarction 66 bosentan 66 voriconazole 66 pericardial effusions 66 LV dysfunction 66 cardioembolic stroke 66 intracranial bleeding 66 postoperative mortality 66 AVANDIA 66 reoperations 66 lactic acidosis 66 unfractionated heparin 66 thrombophlebitis 66 subtrochanteric 66 β blocker 66 mcg QD 66 leucopenia 66 dosage regimens 66 macrovascular events 66 anterior uveitis 66 recurrent atrial fibrillation 66 silent ischemia 66 adalimumab 66 virological failure 66 amiodarone 66 recanalization 66 angiotensin converting enzyme inhibitors 66 ventricular arrhythmias 66 inflammatory lesions 66 noncardiac 66 FOLPI 66 composite endpoint 66 ropivacaine 66 antibiotic prophylaxis 66 abacavir lamivudine 66 stent thrombosis 66 coronary revascularization 66 infective endocarditis 66 lipid lowering therapy 66 vertebral fractures 66 thrombosis 66 antiplatelet agent 66 parecoxib 66 aminotransferases 66 PROMACTA 66 alpha interferons 66 ULORIC 66 nonischemic 66 hematological adverse 66 malignant neoplasms 66 oxycodone CR 66 binary restenosis 66 plasminogen activators 66 dalteparin 66 reintervention 66 ventricular fibrillation VF 66 nicardipine 66 chlorambucil 66 pneumonectomy 66 PEGylated interferon beta 1a 66 ACTOplus met XR 66 renal impairment 66 carotid artery blockage 66 TAVR 66 metastatic GIST 66 stenoses 66 enoxaparin 66 antimicrobial prophylaxis 66 NSTEMI 66 indomethacin 66 Ranolazine 66 hydroxymethyl coenzyme 66 aortic insufficiency 66 LHRH agonists 66 systemic corticosteroids 66 salmeterol fluticasone 66 biochemical recurrence 66 antiplatelet medication 66 dual antiplatelet therapy 66 ARCALYST ® 66 ibandronate 66 thrombotic 66 angiotensin converting enzyme inhibitor 66 laboratory abnormalities 66 cirrhotic patients 66 vandetanib 66 proteinuria 66 tolvaptan 66 acute GvHD 66 adrenal insufficiency 66 oral diclofenac 66 candidemia 65 cholecystitis 65 systemic corticosteroid 65 cardiovascular hospitalization 65 NOLVADEX 65 alteplase 65 infarct size 65 arterial thrombotic 65 intravitreal injections 65 hyperphenylalaninemia HPA due 65 rosuvastatin #mg 65 amenorrhoea 65 VTE 65 nonfatal stroke 65 ventricular dysfunction 65 pulmonary toxicity 65 VT VF 65 edoxaban 65 deferiprone 65 postoperative infections 65 DAPT 65 parathyroidectomy 65 FluCAM arm 65 concomitant medications 65 Atacand 65 5-FU/LV 65 sustained ventricular tachycardia 65 atrial arrhythmias 65 ZYVOX 65 CsA 65 oral anticoagulation 65 FRAGMIN 65 sirolimus eluting stents 65 antiplatelet drugs 65 repeat revascularization 65 androgen suppression 65 prostate cancer CaP 65 thrombocytopenic 65 abdominal adiposity 65 spine fractures 65 DLTs 65 colorectal carcinoma 65 efalizumab 65 mg kg dose 65 ramipril 65 cytopenias 65 stent thromboses 65 Angioedema 65 colorectal adenomas 65 tapentadol ER 65 Doxil ® 65 docetaxel Taxotere ® 65 pharmacokinetic interactions 65 neutropenia dehydration dyspnea 65 systemic toxicity 65 gadobutrol 65 DOXIL 65 glycated hemoglobin levels 65 oral antidiabetic medication 65 tumor recurrence 65 alanine aminotransferase 65 NOXAFIL 65 bone marrow suppression 65 sulfasalazine 65 Dasatinib 65 APTIVUS ritonavir 65 decitabine 65 azacitidine 65 nadroparin 65 CIMZIA TM 65 recurrent glioblastoma multiforme 65 Octreolin 65 trimethoprim sulfamethoxazole 65 HBeAg seroconversion 65 lipid lowering agents 65 sotalol 65 endarterectomy 65 paroxetine Paxil 65 perioperatively 65 warfarin therapy 65 ketorolac 65 Navelbine 65 valvulopathy 65 clodronate 65 thalidomide Thalomid 65 severe hypoglycemic 65 ticagrelor 65 TAXUS Stent 65 lipid lowering drugs 65 RLAI 65 haloperidol Haldol 65 events MACE 65 Hydroxyurea 65 octreotide 65 ABCB1 65 occlusive disease 65 non selective NSAIDs 65 variceal hemorrhage 65 stent implantation 65 acetabular dysplasia 65 IFN beta 65 hepatocellular carcinoma HCC 65 moderate renal impairment 65 severe hypoglycemia 65 fibrinolysis 65 Events MACE 65 thrombolytic therapy 65 anti arrhythmic drugs 65 LNG IUS 65 basal cell carcinoma BCC 65 LVEF 65 haemorrhagic stroke 65 intima media thickness 65 invasive fungal infections 65 epistaxis 65 irbesartan 65 Durezol 65 temsirolimus 65 PASI scores 65 lymphadenectomy 65 fibrinolytic therapy 65 rivaroxaban 65 microvascular disease 65 hypoglycemic episodes 65 cangrelor 65 alfuzosin 65 deep venous thrombosis 65 invasive aspergillosis 65 CIMZIA ™ 65 hypocalcemia 65 hypersensitivity reactions 65 vinorelbine 65 postprocedure 65 nonfatal myocardial infarction 65 BENICAR HCT 65 unfractionated heparin UFH 65 variceal 65 postoperative delirium 65 neurologic symptoms 65 arterial thrombosis 65 pamidronate 65 T2DM 65 advanced adenoma 65 thiazide diuretic 65 ECG abnormalities 65 hepatorenal syndrome 64 ALND 64 ritonavir boosted 64 morphometric vertebral fractures 64 thyrotoxicosis 64 NMIBC 64 candesartan 64 platelet inhibition 64 cerebral infarction 64 caspofungin 64 otamixaban 64 plasma uric acid 64 conjugated equine estrogen 64 INFERGEN 64 subclinical hypothyroidism 64 systolic dysfunction 64 beclomethasone dipropionate 64 solifenacin 64 TACE 64 pulmonary exacerbations 64 hepatic metastases 64 interferon alfa 2b 64 plasma kallikrein inhibitor 64 colorectal liver metastases 64 STRIDE PD 64 DES implantation 64 Aggrenox R 64 thrombus aspiration 64 micafungin 64 events AEs 64 flecainide 64 mitoxantrone 64 paricalcitol 64 adriamycin 64 BYSTOLIC 64 bivalirudin 64 mycophenolic acid 64 primidone 64 mcg BID 64 dopaminergic therapy 64 hematological toxicity 64 curative resection 64 post thrombotic syndrome 64 spinal cord compression 64 cranial irradiation 64 urothelial carcinoma 64 Pulmonary embolism 64 cardiotoxicity 64 pulmonary artery banding 64 tigecycline 64 antihypertensive medications 64 elevated serum creatinine 64 elective PCI 64 metoprolol tartrate 64 Thrombolysis 64 conjunctival hyperemia 64 cytoreductive surgery 64 atrioventricular block 64 noninferior 64 venous thromboembolism VTE 64 zoledronic acid 64 doxorubicin docetaxel 64 incidence ≥ 64 cryptogenic stroke 64 LMWH 64 renal artery stenosis 64 Eltrombopag 64 aldosterone antagonist 64 platelet reactivity 64 ventricular tachyarrhythmias 64 postoperative complications 64 myelosuppression 64 cabazitaxel 64 Pioglitazone 64 fosamprenavir 64 induce orthostatic hypotension 64 malignant neoplasm 64 INTEGRILIN R 64 IOP lowering 64 recurrent myocardial infarction 64 CTEPH 64 glomerular filtration 64 chronic GVHD 64 candesartan cilexetil 64 delayed CINV 64 NSAID induced 64 coronary intervention 64 venous blood clots 64 pelvic lymphadenectomy 64 postoperative bleeding 64 adrenal suppression 64 reoperation 64 INVEGA ® 64 abacavir 64 transthoracic 64 events SAEs 64 dabigatran etexilate 64 mg BID 64 chemoradiation therapy 64 polyp recurrence 64 ACTOplus met 64 atrophic gastritis 64 superficial bladder cancer 64 arterial occlusion 64 serum phosphorous 64 periprocedural MI 64 neurologic deficits 64 sirolimus eluting stent 64 Pemetrexed 64 xanthine oxidase inhibitor 64 hypoxemia 64 serum phosphate 64 celecoxib 64 cerebral ischemia 64 HMG CoA reductase inhibitor 64 postoperative chemotherapy 64 stent restenosis 64 P = .# 64 biologic DMARD 64 lichen planus 64 thienopyridines 64 immunosuppressive agents 64 intraventricular hemorrhage 64 insulin detemir 64 nonmetastatic prostate cancer 64 distant metastases 64 gout flare 64 transaminases 64 elevated IOP 64 symptomatic paroxysmal AF 64 myocardial reperfusion 64 adenoma recurrence 64 adenoma 64 liver transaminases 64 pegylated liposomal doxorubicin 64 NNT = 64 peripheral sensory neuropathy 64 liposomal amphotericin B 64 Non inferiority 64 receiving VELCADE 64 steroid dexamethasone 64 intra abdominal abscess 64 immunomodulatory therapy 64 anti androgen 64 nonrandomized 64 bisphosphonate therapy 64 cinacalcet 64 radicular pain 64 claudication 64 romiplostim 64 hsCRP levels 64 isoproterenol 64 cytogenetic abnormalities 64 Serious adverse reactions 64 HeFH 64 REVLIMID ® 64 selective NSAIDs 64 GnRH agonist 64 anticoagulant therapy 64 hypercholesterolaemia 64 anaphylactoid reactions 64 tocilizumab 64 venous thromboembolic disease 64 bolus dose 64 glycoprotein IIb IIIa inhibitors 64 Peripheral edema 64 ocular toxicity 64 CYPHER ® 64 mycophenolate mofetil MMF 64 Myfortic 64 benazepril 64 superficial femoral 64 serum urate 64 metastatic malignant 64 pimecrolimus 64 telmisartan 64 hypophosphatemia 64 artery stenosis 64 antiplatelet medications 64 serum aminotransferase levels 64 secondary hyperparathyroidism 64 HGPIN 64 pioglitazone 64 upper GI tract 64 phenytoin 64 total thyroidectomy 64 antithrombotics 64 zonisamide SR 64 GISTs 64 #mg BID [003] 64 virologic breakthrough 64 hypotension 64 serum creatinine levels 64 ivabradine 64 node metastases 64 pathologic fractures 64 creatinine clearance 64 AST ALT 64 tenecteplase 64 acute aortic dissection 64 systemic hypotension 64 hyperprolactinemia 64 nonhematologic adverse reactions 64 chlorthalidone 64 valdecoxib 64 aortic regurgitation 64 rt PA 63 liver transplant recipients 63 cardiovascular ischemic 63 parathyroid carcinoma 63 deep vein thromboses 63 retinal vein occlusion 63 VTE prophylaxis 63 leukotriene receptor antagonists 63 Aprotinin 63 iodixanol 63 GERD symptoms 63 TDF FTC 63 resectable 63 PAOD 63 myelodysplastic myeloproliferative diseases 63 systemic absorption 63 pathologic fracture 63 hyperalgesia 63 refractory ischemia 63 microbleeds 63 antihypertensive therapy 63 CIMZIA TM certolizumab pegol 63 LEXIVA r 63 olmesartan 63 thrombo embolic 63 erythropoietic 63 hemodynamic instability 63 neurologic complications 63 Cardiopulmonary bypass 63 venous thromboembolic 63 urate lowering 63 CMV infection 63 invasive coronary angiography 63 Thrombotic events 63 relapsed MM 63 extracranial 63 proton pump inhibitor PPI 63 LEXIVA 63 intestinal metaplasia 63 bypass grafting 63 Unstable Angina 63 paroxysmal atrial fibrillation 63 corrected QT interval 63 serum ALT 63 intracerebral haemorrhage 63 PCa 63 DMARD 63 CANCIDAS 63 virologic response 63 asthma exacerbation 63 liver histology 63 hepatocellular 63 etanercept 63 UA NSTEMI 63 pCR 63 PLAVIX 63 venous thromboembolisms 63 lispro 63 atypical femur fractures 63 adjunctive placebo 63 aspartate aminotransferase 63 sorafenib Nexavar 63 syncope fainting 63 gastroduodenal 63 terazosin 63 neoadjuvant therapy 63 hypertrophic scars 63 Oral corticosteroids 63 infusional 5-FU/LV 63 choroidal neovascularization 63 urate lowering therapy 63 abatacept 63 aminotransferase ALT 63 daunorubicin 63 fragility fracture 63 arteriography 63 ezetimibe simvastatin 63 elevated intraocular pressure 63 limiting toxicity 63 abnormal uterine bleeding 63 receiving prophylactic anticoagulation 63 surgical revascularization 63 INCB# [003] 63 radiotherapy RT 63 comorbid conditions 63 chemoembolization 63 discontinuations 63 chemoradiation 63 KIF6 carriers 63 sirolimus 63 bowel resection 63 nonfatal myocardial infarction MI 63 atheroma volume 63 OAB symptoms 63 corticosteroid dose 63 Hypersensitivity reactions 63 Aggrastat ® tirofiban hydrochloride 63 RoACTEMRA 63 infarction STEMI 63 oxcarbazepine 63 oral anticoagulant 63 clevidipine 63 gastric adenocarcinoma 63 elevated troponin 63 somatostatin analog 63 atorvastatin #mg 63 riociguat 63 CDI recurrence 63 MICARDIS ® 63 Venous thromboembolism 63 ADHF 63 ICD implantation 63 epoetin beta 63 dexrazoxane 63 KETEK 63 invasive ductal 63 GP IIb IIIa inhibitor 63 adjunctive ABILIFY 63 ruboxistaurin 63 nab paclitaxel 63 visilizumab 63 thrombocytosis 63 DU #b 63 MYCAMINE 63 pomalidomide 63 DVT PE 63 ADPKD 63 Torisel 63 enalapril 63 EFFEXOR XR 63 acute coronary syndrome 63 malperfusion 63 spontaneous preterm delivery 63 rhythm disturbances 63 certolizumab 63 metastatic renal cell carcinoma 63 necrotizing pancreatitis 63 symptomatic BPH 63 zolmitriptan 63 mg QD 63 FAMPYRA 63 HBeAg positive patients 63 revascularization procedure 63 splenectomized patients 63 coronary blockages 63 haematological toxicity 63 overt nephropathy 63 acitretin 63 renal scarring 63 canakinumab 63 carotid IMT 63 sinus tachycardia 63 angioplasty stenting 63 angiotensin receptor blocker ARB 63 non squamous NSCLC 63 XGEVA 63 valsartan 63 LOVENOX R 63 lymphadenopathy 63 5FU 63 metabolic acidosis 63 DFMO 63 hepatic impairment 63 CK MB 63 thrombolytics 63 Subgroup analyzes 63 ranolazine 63 Taxus Stent 63 locoregional 63 vitreous hemorrhage 63 dutasteride 63 cardiovascular hospitalizations 63 FRAGMIN R 63 lipid lowering therapies 63 epirubicin 63 desvenlafaxine succinate 63 esophagogastric 63 grade glioma 63 events TEAEs 63 ELOXATIN 63 troponin T 63 oral rivaroxaban 63 NSAID 63 cardiac repolarization 63 varices 63 neutropenic patients 63 Adjuvant chemotherapy 63 ACTEMRA TM 63 plus gemcitabine 63 calcineurin inhibitors 63 dacarbazine 63 stage IIIB 63 achieved ACR# 63 vesicoureteral reflux 63 antiarrhythmic 63 transdermal estrogen 63 erythema nodosum 63 fallopian tube cancers 63 tipranavir 63 imipenem 63 hydroxychloroquine 63 thromboembolic disorders 63 AGILECT R 63 clinically meaningful reductions 63 CYP #A# 63 primary aldosteronism 63 anticoagulant warfarin 63 hypercholesterolemia 63 COPD exacerbation 63 aldosterone antagonists 63 ancrod 63 patients undergoing percutaneous 63 unstable angina 63 oral anticoagulant therapy 63 heavy menstrual bleeding 63 tamponade 63 liver metastasis 63 #mg/m# [001] 63 lacosamide 63 hemorrhagic strokes 63 hallucinations dyskinesia 63 BoNTA 63 neoplastic lesions 63 antithrombotic 63 Carvedilol 63 oral anticoagulants 63 nonoperative treatment 63 basal cell cancers 63 Infusion Reactions Severe 63 POAG 63 Teriflunomide 63 ribavirin therapy 63 headache nasopharyngitis 63 quetiapine 63 nocturnal hypoglycaemia 63 placebo dexamethasone 63 antidiabetic drug 63 cholelithiasis 63 gastrointestinal GI bleeding 63 hypokalemia 63 oral corticosteroids 63 LOVENOX 63 unresectable HCC 63 Restenosis 63 nondiabetic patients 63 ventricular tachycardia VT 63 mCRC patients 63 endometrial thickness 63 Flu Cy 63 pentoxifylline 63 Renal impairment 63 grade cervical intraepithelial 63 Statin therapy 63 histological subtype 63 infusional 63 comparator arm 63 skeletal metastases 63 hypoperfusion 63 lymphopenia 63 neoadjuvant 63 carboplatin paclitaxel 63 bisoprolol 63 sinus bradycardia 63 anemia neutropenia 63 tiotropium 63 ischemia driven 63 ABC/3TC 63 tachyarrhythmias 63 recurrent miscarriage 63 tardive dyskinesia TD 63 cardiac dysfunction 63 gastrointestinal adverse reactions 63 vaginal hysterectomy 63 alpha blocker 63 hyperammonemia 63 PEGINTRON TM 63 rosuvastatin 63 NNRTI resistance 63 malabsorptive 62 PSADT 62 colectomy 62 conventional angiography 62 ablative therapy 62 venlafaxine Effexor 62 intraocular inflammation 62 dose limiting toxicities 62 PREMPRO 62 carcinoids 62 alemtuzumab treated 62 cerebral microbleeds 62 Carotid endarterectomy 62 ketoconazole 62 danazol 62 nonoperative 62 atherothrombosis 62 piperacillin tazobactam 62 rizatriptan 62 QTc intervals 62 tipranavir r 62 Keppra R 62 endoleaks 62 intracerebral 62 acarbose 62 receiving INTRON 62 Fludara 62 detrusor overactivity 62 everolimus eluting stents 62 osteopenic 62 pyrexia mucositis sepsis febrile 62 gouty arthritis 62 pulmonary emboli 62 NYHA Class II 62 valacyclovir 62 ALT elevations 62 histologic subtype 62 primary hyperparathyroidism 62 Noxafil 62 Elitek 62 Renal dysfunction 62 serum calcium levels 62 reflux symptoms 62 glucocorticoid induced osteoporosis 62 genotypic resistance 62 FROVA 62 renal tumors 62 icatibant 62 serum potassium

Back to home page